Disease activity following pregnancy-related discontinuation of natalizumab in MS.

about

Rituximab before and during pregnancy: A systematic review, and a case series in MS and NMOSD.

P2860

Q55442184-192857AD-65BC-4D27-85FF-8C8F652CFC8F

P2860

Disease activity following pregnancy-related discontinuation of natalizumab in MS.

Item

http://www.wikidata.org/entity/Q49590553

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Disease activity following pregnancy-related discontinuation of natalizumab in MS.

@en

Disease activity following pregnancy-related discontinuation of natalizumab in MS.

@nl

type

Item

label

Disease activity following pregnancy-related discontinuation of natalizumab in MS.

@en

Disease activity following pregnancy-related discontinuation of natalizumab in MS.

@nl

prefLabel

Disease activity following pregnancy-related discontinuation of natalizumab in MS.

@en

Disease activity following pregnancy-related discontinuation of natalizumab in MS.

@nl

P1476

Disease activity following pregnancy-related discontinuation of natalizumab in MS

@en

P2093

Bernard M J Uitdehaag

http://www.w3.org/2001/XMLSchema#string

Birgit I Lissenberg-Witte

http://www.w3.org/2001/XMLSchema#string

Brigit A de Jong

http://www.w3.org/2001/XMLSchema#string

Cyra E Leurs

http://www.w3.org/2001/XMLSchema#string

Iris Dekker

http://www.w3.org/2001/XMLSchema#string

Joep Killestein

http://www.w3.org/2001/XMLSchema#string

Mike P Wattjes

http://www.w3.org/2001/XMLSchema#string

Theo Rispens

http://www.w3.org/2001/XMLSchema#string

Zoé L E van Kempen

http://www.w3.org/2001/XMLSchema#string

P2860

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

Defining the clinical course of multiple sclerosis: the 2013 revisions.

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

MS disease activity in RESTORE: a randomized 24-week natalizumab treatment interruption study.

Incidence of early loss of pregnancy.

Conception, early pregnancy loss, and time to clinical pregnancy: a population-based prospective study.

Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy.

Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study

Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function.

What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature.

P304

e424

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/NXI.0000000000000424

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Bob W van Oosten

Caspar E P van Munster

Iris Kleerekooper

P577

2017-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29379823

http://www.w3.org/2001/XMLSchema#string

P932

5778770

http://www.w3.org/2001/XMLSchema#string

Disease activity following pregnancy-related discontinuation of natalizumab in MS.

about

P2860

P2860

Disease activity following pregnancy-related discontinuation of natalizumab in MS.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932